Profile image
By ProactiveInvestors (Reporter)
Contributor profile | More stories
Story Views

Last Hour:
Last 24 Hours:

Biovault tie-up a ‘landmark development’ for WideCells Group PLC

Monday, November 7, 2016 4:37
% of readers think this story is Fact. Add your two cents.

WideCells Group’s (LON:WDC) subsidiary CellPlan has signed a non-binding letter of intent to offer its stem cell treatment insurance to clients of the human tissue storage facility Biovault Technical. Biovault has a register of over 25,000 customers which WideCells will have access to for an initial five year term.

WideCells CEO chief executive João Andrade tells Proactive: ”This is a very important landmark for us because we have developed the product and now the market’s responding positively to it. This letter of intent will allow us to have access directly to around 25,000 clients who Biovault currently has through their own company and also its affiliates and that will enable us to be able to rollout CellPlan during the course of next year”.

”What we’ll be doing, until the end of this year, is developing together with Biovault, an implementation plan and a market roll out plan because Biovault is operating in several countries – not just in the UK”,  Andrade added.

Story by ProactiveInvestors


We encourage you to Share our Reports, Analyses, Breaking News and Videos. Simply Click your Favorite Social Media Button and Share.

Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Top Global


Top Alternative




Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.